argenx Gets FDA Nod for VYVGART Self-Injection Prefilled Syringe
argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that...
Tag : disease management
Datar Cancer Genetics Launches Tumor-Agnostic MRD Blood Test
The Target-MRD blood test uses a combination of tumor-informed and tumor-agnostic molecular features for personalized, accurate and more effective monitoring of molecular residual disease. Datar...